Connor, Clark & Lunn Investment Management (CC&L)
MRNS

Connor, Clark & Lunn Investment Management (CC&L)’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio MRNS Stock Details MRNS Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-23,335
Closed -$253K – 1591
2023
Q2 		$253K Buy
+23,335
New +$253K ﹤0.01% 1147